US Patent 7544701 Sulfonyldihydrobenzimidazolone compounds as 5-hydroxytryptamine-6 ligands
Patent 7544701 was granted and assigned to Wyeth on June, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+201 characters)
Article
Patent abstract
The present invention provides a compound of formula I and the use thereof in the therapeutic treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07544701 Sulfonyldihydrobenzimidazolone compounds as 5-hydroxytryptamine-6 ligands US Patent 7544701 Sulfonyldihydrobenzimidazolone compounds as 5-hydroxytryptamine-6 ligands
Infobox
Patent Number
0754470100
Patent Number
754470100
Edits on 3 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075447010
Date of Patent
June 9, 2009
0Patent Application Number
108971530
Date Filed
July 22, 2004
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075447010
Date of Patent
June 9, 2009
0Patent Application Number
108971530
Date Filed
July 22, 2004
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07544701 Sulfonyldihydrobenzimidazolone compounds as 5-hydroxytryptamine-6 ligands
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07544701
Date of patent
June 9, 2009
Patent application number
10897153
Date Filed
July 22, 2004
Patent primary examiner
Find more entities like US Patent 7544701 Sulfonyldihydrobenzimidazolone compounds as 5-hydroxytryptamine-6 ligands
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
